Article

Bausch & Lomb PureVision contact lenses available

Bausch & Lomb's PureVision contact lenses are available in the United States once again, following the recent successful resolution of a patent dispute.

May 1

- Fort Lauderdale, FL - Bausch & Lomb's PureVision contact lenses are available in the United States once again, following the recent successful resolution of a patent dispute.

The silicone hydrogel lenses can be prescribed for daily wear or continuous wear for up to 30 days and nights, according to Paul G. Howes, president of Bausch & Lomb North America. "The PureVision lens design provides wearers exceptional vision, health, and comfort, whether the lenses are removed each day or worn 30 days straight, including overnight," Howes said.

Ophthalmologists and optometrists across the United States soon will receive the lens sets, containing a range of PureVision lens prescription powers, to help fit their patients. More information is available at www.purevision.com.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
© 2025 MJH Life Sciences

All rights reserved.